Português
Español
It provides a forum for WHO member states to collaborate in monitoring drug safety. Within the programme, individual case reports of suspected adverse drug reactions are collected.
Originator(s): World Health Organization - WHO, WHO Collaborating Centre for International Drug Monitoring / Uppsala Monitoring Centre - UMC.
Resource added in:
28/11/2001
Available languages:
English
comments powered by Disqus
